From January 1, 2024 to March 31, 2024, the company has repurchased 8,575,800 shares, representing 1.67% for CNY 70.58 million. With this, the company has completed the repurchase of 8,575,800 shares, representing 1.67% for CNY 70.58 million under the buyback announced on October 29, 2023.
Shanghai Kehua Bio-Engineering Co.,Ltd
Equities
002022
CNE000001KC9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.39 CNY | -2.25% | +0.41% | -35.06% |
28/04 | Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/04 | Kehua Bio-Engineering Gets Registration Certificates for Two Devices | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.06% | 529M | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+25.61% | 5.27B | |
-4.58% | 4.49B | |
-51.80% | 3.11B | |
+16.25% | 2.87B | |
+30.25% | 2.31B | |
-4.08% | 1.89B |
- Stock Market
- Equities
- 002022 Stock
- News Shanghai Kehua Bio-Engineering Co.,Ltd
- Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.